Dagpin, Jeanelie P.
HRN: 22-26-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2023
CEFUROXIME 500MG (TAB)
01/01/2023
01/08/2023
PO
500 Mg
BID
S/P Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes